Literature DB >> 9463937

Inhibition of succinic dehydrogenase and F0F1-ATP synthase by 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS).

C F Bernardes1, J R Meyer-Fernandes, O B Martins, A E Vercesi.   

Abstract

This study shows that incubation of rat liver mitochondria in the presence of the thiol/ amino reagent 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) is followed by inhibition of both succinate supported respiration and oxidative phosphorylation. Half-maximal inhibition of succinic dehydrogenase activity and succinate oxidation by mitochondria was attained at 55.3 and 60.8 microM DIDS, respectively. DIDS did inhibit the net ATP synthesis and ATP<=>[32P]Pi exchange reaction catalyzed by submitochondrial particles in a dose-dependent manner (Ki = 31.7 microM and Ki = 32.7 microM), respectively. The hydrolytic activities of uncoupled heart submitochondrial particles and purified F1-ATPase were also inhibited 50% by 31.9 and 20.9 microM DIDS, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9463937     DOI: 10.1515/znc-1997-11-1212

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  4 in total

Review 1.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 2.  A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase.

Authors:  Zulfiqar Ahmad; Sherif S Hassan; Sofiya Azim
Journal:  Curr Med Chem       Date:  2017-11-20       Impact factor: 4.530

Review 3.  Effects of Tl+ on the inner membrane thiol groups, respiration, and swelling in succinate-energized rat liver mitochondria were modified by thiol reagents.

Authors:  Sergey M Korotkov
Journal:  Biometals       Date:  2021-07-08       Impact factor: 2.949

4.  Isothiocyanatostilbenes as novel c-Met inhibitors.

Authors:  Alana L Gray; David T Coleman; Reneau F Castore; Mohamed M Mohyeldin; Khalid A El Sayed; James A Cardelli
Journal:  Oncotarget       Date:  2015-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.